Singapore markets close in 3 hours 31 minutes

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
802.16+50.86 (+6.77%)
At close: 04:00PM EDT
800.17 -1.99 (-0.25%)
After hours: 07:56PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
3,105,900
2,885,600
2,193,700
1,617,800
Other short-term investments
4,636,400
2,809,100
1,393,300
1,596,500
Total cash
7,742,300
5,694,700
3,587,000
3,214,300
Net receivables
5,328,700
6,036,500
3,516,200
2,672,200
Inventory
1,880,100
1,951,300
1,916,600
1,415,500
Total current assets
15,884,100
14,014,900
9,779,100
7,689,100
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
5,432,200
4,880,300
4,352,700
3,812,800
Accumulated depreciation
-1,669,200
-1,398,100
-1,131,100
-922,400
Net property, plant and equipment
3,763,000
3,482,200
3,221,600
2,890,400
Equity and other investments
5,406,400
6,838,000
3,135,600
3,256,800
Intangible assets
915,500
-
-
-
Other long-term assets
1,521,800
222,800
168,100
144,700
Total non-current assets
13,330,400
11,419,900
7,384,200
7,116,100
Total assets
29,214,500
25,434,800
17,163,300
14,805,200
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
589,200
564,000
475,500
418,100
Taxes payable
300
326,300
19,500
49,400
Accrued liabilities
2,063,400
1,593,100
1,502,300
1,037,400
Deferred revenues
477,900
442,000
577,700
591,700
Other current liabilities
-
-
122,400
-
Total current liabilities
3,141,300
3,932,500
2,697,400
2,096,600
Non-current liabilities
Long-term debt
1,981,400
1,980,000
1,978,500
-
Deferred revenues
69,800
73,300
57,800
619,000
Other long-term liabilities
638,000
680,200
687,100
286,000
Total non-current liabilities
3,409,200
2,733,500
3,440,600
1,618,900
Total liabilities
6,550,500
6,666,000
6,138,000
3,715,500
Stockholders' equity
Common stock
100
100
100
100
Retained earnings
23,306,700
18,968,300
10,893,000
7,379,800
Accumulated other comprehensive income
-238,800
-26,200
29,300
21,100
Total stockholders' equity
22,664,000
18,768,800
11,025,300
11,089,700
Total liabilities and stockholders' equity
29,214,500
25,434,800
17,163,300
14,805,200